Schedule 13G ownership disclosure

Aptevo Therapeutics Inc (US) OLD

Common Stock, $0.001 par value · CUSIP: 03835L405

Event date: 2024-12-31

Filing-level shares
76,598.00
Percent of class
4.99%
  • Hudson Bay Capital Management LP

    Shares: 76,598.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002033916-25-000004
Form type
SCHEDULE 13G/A
Filer
Aptevo Therapeutics Inc.
CIK
CIK 1671584
Filed
Feb 10, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub